新产品上线! Email验证工具 - 限时免费试用中立即试用

外贸营销群发邮件之前,先批量验证邮箱地址是否有效,可节省成本,提高发送成功率,减少被列入黑名单风险。 更多需求:邮箱采集/邮件群发

手动筛选如何与 REACH 或 CLP 下的其他流程相衔接?一种物质是否可以不经过筛选(例如,具有统一分类和标签的物质、SVHC 物质)而直接进入某个监管流程(例如,CoRAP、SVHC)?

问题(中文)
手动筛选如何与 REACH 或 CLP 下的其他流程相衔接?一种物质是否可以不经过筛选(例如,具有统一分类和标签的物质、SVHC 物质)而直接进入某个监管流程(例如,CoRAP、SVHC)?
Question (EN)
How is manual screening linked with other processes under REACH or CLP? Can a substance enter one regulatory process (e.g. CoRAP, SVHC) without being screened (e.g. a substance with a harmonised classification and labelling, SVHC substance)?
中文内容由 Google Cloud Translation 自动生成,仅供参考;请以英文原文为准。问答资料来自欧盟化学品管理局(ECHA)官方网站。
答案(中文)
在手动筛选过程中,MSCA 会确定某种物质是否需要采取监管行动,如果需要,则确定最合适的行动。因此,这是大多数物质进入 REACH 或 CLP 下其他流程的第一步。但是,成员国可以随时提名某种物质进入 CoRAP 或对任何物质采取监管行动,因此某种物质有可能直接进入 CoRAP、RMOA(PACT 清单)或监管风险管理,而无需手动筛选。MSCA 可以根据其优先级方案选择物质,但会尽一切努力确保所有 MSCA 和 ECHA 合作进行共同筛选。但请注意,成员国之间普遍同意,在提名将某种物质确定为 SVHC 或进行限制流程之前,先完成 RMOA。
Answer (EN)
During manual screening, MSCAs determine whether regulatory action is needed for a substance and if so, which is the most appropriate action.  It is therefore the first step for most substances entering the other processes under REACH or CLP. However, Member States can propose a substance for the CoRAP or initiate regulatory action on any substance at any time so it is possible for a substance to go straight to the CoRAP, RMOA (PACT listing) or regulatory risk management without manual screening. MSCAs may select substances based on their prioritisation schemes, although every effort is made so that all MSCAs and ECHA collaborate in common screening. Note though that there is a general agreement among Member States to have a RMOA done first before proposing a substance for being identified as an SVHC or to go through the restriction process.